This inventor holds 18 USPTO granted patents, plus 2 CIPO patents, primarily in Nitric Oxide Synthase Inhibitors. Top assignees: G.d. Searle & Company, Pharmacia Corporation, Monsanto Company. Active years: 1987-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
11 out of 1,323 
4 out of 220 
3 out of 3,289 
Years Active: 1987-2007
Areas of Expertise:
Title: The Innovations of Kam F. Fok: A Leading Inventor in Nitric Oxide Synthase Inhibition
Introduction: Kam F. Fok is a prominent inventor based in St. Louis, Missouri, recognized for his significant contributions to the field of medicinal chemistry. With a total of 18 patents to his name, he has made remarkable advances, particularly in the development of compounds that function as nitric oxide synthase inhibitors. His innovative approaches have garnered attention in both academic and industrial circles.
Latest Patents: Among his latest patents, Fok developed amidino compounds and their salts, which serve as effective nitric oxide synthase inhibitors. The patent details not only the compounds but also their therapeutic uses and methods of preparation. Additionally, Fok has focused on methods for synthesizing alpha-amino acid compounds through hydrolyzing conditions, showcasing his versatility and depth in chemical innovation.
Career Highlights: Throughout his career, Kam F. Fok has made substantial strides in the pharmaceutical industry. He has worked with notable companies such as G.D. Searle & Company and Pharmacia Corporation, where he has applied his expertise in medicinal chemistry to develop new therapeutic agents. His extensive knowledge of chemical compounds has been instrumental in paving the way for innovative therapies.
Collaborations: Fok’s collaborations with researchers have played a vital role in his successful patent applications. Among his colleagues, Timothy J. Hagen and E. Ann Hallinan stand out as key contributors to his research endeavors. These partnerships not only enriched his work but also fostered a collaborative environment that has enhanced the efficacy of the innovations developed.
Conclusion: Kam F. Fok’s work as an inventor has had a significant impact in the field of nitric oxide synthase inhibition. His inventions, underscored by a robust patent portfolio, highlight his commitment to advancing medicinal chemistry. With continued collaboration and innovation, Fok is poised to further contribute to therapeutic developments in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile